 |
|
|
 |
VOLUME 32: NO. 10 OCTOBER 2005
Editorials
Preventing Deaths from Methotrexate Overdose
Use of Low-Dose Glucocorticoids and the Risk of Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis: What Is the True Direction of Effect?
Steroids for Rheumatoid Arthritis: The Honeymoon Revisited (Once Again)
Malignancy and Rheumatic Disease — A Real Association?
Bone Mineral Content versus Bone Density in a Population with Osteoarthritis: A New Twist to the Controversy?
ADAM Proteins as Therapeutic Targets in
Loosening of Total Hip Replacement Implants?
Race, Scleroderma, and Survival: Why Is There a Difference?
Articles
Household Income and Earnings Losses Among
6,396 Persons with RA
Autoimmune Disease Is a Risk Factor for the Development of Non-Hodgkin's Lymphoma
Demographic and Clinical Factors Associated with
In-Hospital Death Among Patients with SSc
Distinct Expression of Adhesion Molecules on
Skin Fibroblasts from Patients with Diffuse and
Limited SSc. A Pilot Study
The Cochrane Review of Physiotherapy Interventions for AS
IL-1 and NF-kB Polymorphisms in AS in Canada and Korea
Etanercept Exerts Beneficial Effects on Articular Cartilage Biomarkers of Degradation and Turnover in Patients with AS
Prevalence, Disease Manifestations, and Treatment of PsA in Western Norway
Factors Associated with Musculoskeletal Disability
and Chronic Renal Failure in Clinically Diagnosed Primary Gout
Clinical Effects of Intraarticular Injection of High Molecular Weight Hyaluronan (Orthovisc®) in OA of the Knee: A Randomized, Controlled, Multicenter Trial
The Genetic Contribution and Relevance of Knee Cartilage Defects: Case-Control and Sib-Pair Studies
Increased Expression and Processing of ADAM 12 (Meltrin-a) in Osteolysis Associated with Aseptic Loosening of Total Hip Replacement Implants
Increased Bone Mineral Content But Not BMD in the Hip in Surgically Treated Knee and Hip OA
Comparative Effects of 2 Antioxidants, Selenomethionine and Epigallocatechin-Gallate,
on Catabolic and Anabolic Gene Expression of Articular Chondrocytes
Safety and Tolerability of Oral Daily and Intermittent Ibandronate Are Not Influenced by Age
Efficacy of Milnacipran in Patients with FM
Pediatric Rheumatology
Eye Findings in Patients with JDM
Longitudinal Analysis of a Pediatric Rheumatology Clinic Population Case Reports
Poststreptococcal Reactive Arthritis with Thoracic Spine Involvement in an Adult
Synovial Sarcoma of the Foot Mimicking Acute
Gouty Arthritis
Deaths Following MTX Overdoses by Medical Staff
OMERACT 7 International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials, Asilomar, California, USA, May 8-12, 2004
Introduction
Minimal Disease Activity for RA: A Preliminary Definition
Minimal Clinically Important Difference, Low Disease Activity State, and Patient Acceptable Symptom State: Methodological Issues
Challenges and Progress in Adverse Event Ascertainment and Reporting in Clinical Trials
Generic Patient Self-Report and Investigator Report Instruments of Therapeutic Safety and Tolerability
Standardized Assessment of Adverse Events in Rheumatology Clinical Trials: Summary of the
OMERACT 7 Drug Safety Module Update
Application of the OMERACT Filter to Scoring
Methods for MRI of the Sacroiliac Joints and the
Spine. Recommendations for a Research Agenda at
OMERACT 7
Selection of a Method for Scoring Radiographs for
AS Clinical Trials, by the Assessment in AS Working Group and OMERACT
Scoring Sacroiliac Joints by MRI. A Multiple-Reader Reliability Experiment
MRI of Inflammatory Lesions in the Spine in
AS Clinical Trials: Is Paramagnetic Contrast
Medium Necessary?
Correspondence
Treating Leukocytoclastic Vasculitis Associated with Etanercept Therapy. Is It Necessary to Stop Etanercept?
Reply: Treating Leukocytoclastic Vasculitis Associated with Etanercept Therapy. Is It Necessary to Stop Etanercept?
Letter
CTLA-4 –1661A/G and –;1772T/C Dimorphisms in Japanese Patients with SLE
Correction
Fibromyalgia Syndrome: Review of Clinical Presentation, Pathogenesis, Outcome Measures,
and Treatment
Meetings in Rheumatology......... |
